Access Bio Stock Current Valuation
950130 Stock | KRW 6,260 120.00 1.88% |
Valuation analysis of Access Bio helps investors to measure Access Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Access Bio's price fluctuation is very steady at this time. Calculation of the real value of Access Bio is based on 3 months time horizon. Increasing Access Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Access Bio is useful when determining the fair value of the Access stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Access Bio. Since Access Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Access Stock. However, Access Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 6260.0 | Real 4882.8 | Hype 6260.0 |
The real value of Access Stock, also known as its intrinsic value, is the underlying worth of Access Bio Company, which is reflected in its stock price. It is based on Access Bio's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Access Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Access Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Access Bio helps investors to forecast how Access stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Access Bio more accurately as focusing exclusively on Access Bio's fundamentals will not take into account other important factors: Access Bio Company Current Valuation Analysis
Access Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Access Bio Current Valuation | 1.03 T |
Most of Access Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Access Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Access Bio has a Current Valuation of 1.03 T. This is much higher than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.
Access Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Access Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Access Bio could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics of similar companies.Access Bio is currently under evaluation in current valuation category among related companies.
Access Fundamentals
Return On Equity | 108.02 | |||
Return On Asset | 0.35 | |||
Profit Margin | 0.40 % | |||
Operating Margin | 0.55 % | |||
Current Valuation | 1.03 T | |||
Shares Outstanding | 26.79 M | |||
Shares Owned By Insiders | 25.25 % | |||
Shares Owned By Institutions | 0.08 % | |||
Price To Earning | 149.71 X | |||
Price To Sales | 1.44 X | |||
Revenue | 441.37 M | |||
Gross Profit | 90.63 B | |||
EBITDA | 69.95 B | |||
Net Income | 166.09 M | |||
Cash And Equivalents | 167.93 M | |||
Cash Per Share | 828.78 X | |||
Total Debt | 10.13 M | |||
Debt To Equity | 0.13 % | |||
Current Ratio | 16.48 X | |||
Book Value Per Share | 2,289 X | |||
Cash Flow From Operations | 137.9 M | |||
Number Of Employees | 69 | |||
Beta | 0.28 | |||
Market Capitalization | 292.03 B | |||
Total Asset | 372.85 M | |||
Retained Earnings | 18.8 B | |||
Working Capital | 43.68 B | |||
Current Asset | 45.78 B | |||
Current Liabilities | 2.1 B | |||
Net Asset | 372.85 M |
About Access Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Access Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Access Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Access Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |